In:
Clinical Transplantation, Wiley, Vol. 30, No. 5 ( 2016-05), p. 508-517
Abstract:
The organ shortage has led to increased use of marginal organs. The Eurotransplant Donor‐Risk‐Index ( ET ‐ DRI ) was established to estimate outcome after Liver Transplantation ( LT ). Currently, data on impact of ET ‐ DRI on long‐term outcome for different indications and recipient conditions are missing. Retrospective, single‐center analysis of long‐term graft survival ( GS ) of 1767 adult primary LT s according to indication, lab MELD category ( 1 : ≤18; 2 : 〉 18–25; 3 : 〉 25–35; 4 : 〉 35), and ET ‐ DRI . Mean ET ‐ DRI in our cohort was 1.63 (±0.43). One‐, 10, and 15‐yr GS was 83.5%, 63.3%, and 54.8%. Long‐term GS was significantly influenced by ET ‐ DRI . Accordingly, four ET ‐ DRI categories were defined and analyzed with respect to underlying disease. Significant impact of these categories was observed for: Alcohol, cholestatic/autoimmune diseases ( CD / AIH ), and HCV , but not for HCC , HBV , cryptogenic cirrhosis, and acute liver failure. lab MELD categories showed no significant influence on graft, but on patient survival. Matching ET ‐ DRI categories with lab MELD revealed significant differences in long‐term GS for lab MELD categories 1 , 2 , and 3 , but not 4 . In multivariate analysis, HCV combined with ET ‐ DRI 〉 2 and lab MELD category 3 combined with ET ‐ DRI 〉 2 emerged as negative predictors. To achieve excellent long‐term graft survival, higher risk organs ( ET ‐ DRI 〉 1.4) should be used restrictively for patients with CD / AIH or HCV . Organs with ET‐DRI 〉 2 should be avoided in patients with a lab MELD of 〉 25–35.
Type of Medium:
Online Resource
ISSN:
0902-0063
,
1399-0012
DOI:
10.1111/ctr.2016.30.issue-5
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
2739458-X
detail.hit.zdb_id:
2004801-4
Permalink